Benitec Biopharma CEO to Participate in OPMD Awareness Day Webinar
Benitec Biopharma Inc. (BNTC)
US:NASDAQ Investor Relations:
benitec.com/for-investors/investor-faqs
Company Research
Source: GlobeNewswire
HAYWARD, Calif., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace” DNA-directed RNA interference (“ddRNAi”) platform, today announces CEO Jerel A. Banks, M.D., Ph.D. will participate in the Oculopharyngeal Muscular Dystrophy (OPMD) Awareness Day Webinar organized by the OPMD Association, on Monday, September 23, 2024 at 12 PM EST. The event aims to raise awareness of OPMD, a rare, genetic, adult-onset, progressive myopathy with symptom onset beginning between 40-50 years of age. “I am honored to participate in the inaugural OPMD Awareness Day Webinar along with patients, patient advocates, and a clinician expert, to provide an update on the BB-301 Phase 1b/2a clinical development program,” said Jerel A. Banks, M.D., Ph.D., Executive Chairman and Chief Executive Officer of Benitec. “As part of
Show less
Read more
Impact Snapshot
Event Time:
BNTC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BNTC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BNTC alerts
High impacting Benitec Biopharma Inc. news events
Weekly update
A roundup of the hottest topics
BNTC
News
- Benitec Biopharma Releases Full Year 2024 Financial Results and Provides Operational UpdateGlobeNewswire
- Benitec Biopharma Announces Late Breaking Oral Abstract Presentation on BB-301 Phase 1b/2a Clinical Study at the 29th Annual Congress of the World Muscle SocietyGlobeNewswire
- Benitec Biopharma Inc. (NASDAQ: BNTC) is now covered by analysts at Guggenheim. They set a "buy" rating and a $17.00 price target on the stock.MarketBeat
- Benitec Biopharma Inc. (NASDAQ: BNTC) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.MarketBeat
- Benitec Biopharma Inc. (NASDAQ: BNTC) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $13.00 price target on the stock.MarketBeat
BNTC
Sec Filings
- 9/26/24 - Form 8-K
- 9/26/24 - Form 10-K
- 9/5/24 - Form 8-K
- BNTC's page on the SEC website